Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 29.1 CHF 0.69% Market Closed
Market Cap: 167.1m CHF
Have any thoughts about
Xlife Sciences AG?
Write Note

Xlife Sciences AG
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Xlife Sciences AG
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Xlife Sciences AG
SIX:XLS
Total Receivables
CHf17.9m
CAGR 3-Years
292%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Total Receivables
CHf148.2m
CAGR 3-Years
23%
CAGR 5-Years
18%
CAGR 10-Years
16%
Siegfried Holding AG
SIX:SFZN
Total Receivables
CHf361.5m
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Total Receivables
CHf1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tecan Group AG
SIX:TECN
Total Receivables
CHf206.4m
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Total Receivables
CHf38.4m
CAGR 3-Years
9%
CAGR 5-Years
389%
CAGR 10-Years
N/A
No Stocks Found

Xlife Sciences AG
Glance View

Market Cap
166m CHF
Industry
Life Sciences Tools & Services

Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Zuerich and currently employs 19 full-time employees. The company went IPO on 2019-09-30. The firm focuses on investing in technologies in the life science industry. The company supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The firm offers its investors direct access to the further development of technologies at a very early stage. The firm cooperates with industrial partners and universities.

XLS Intrinsic Value
1.37 CHF
Overvaluation 95%
Intrinsic Value
Price

See Also

What is Xlife Sciences AG's Total Receivables?
Total Receivables
17.9m CHF

Based on the financial report for Dec 31, 2023, Xlife Sciences AG's Total Receivables amounts to 17.9m CHF.

What is Xlife Sciences AG's Total Receivables growth rate?
Total Receivables CAGR 3Y
292%

Over the last year, the Total Receivables growth was 1 770%. The average annual Total Receivables growth rates for Xlife Sciences AG have been 292% over the past three years .

Back to Top